PTP — Pentixapharm Holding AG Cashflow Statement
0.000.00%
- €61.76m
- €61.97m
- €0.09m
Annual cashflow statement for Pentixapharm Holding AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2010 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 52 W | 41 W | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 0 | -12.8 | -16.5 |
| Depreciation | |||
| Deferred Taxes | |||
| Non-Cash Items | — | -0.036 | 0.145 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | — | -6.78 | -2.32 |
| Change in Accounts Receivable | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Cash from Operating Activities | — | -4.33 | -18 |
| Capital Expenditures | — | -0.001 | -0.625 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | — | 8.24 | — |
| Acquisition of Business | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | — | 8.24 | -0.625 |
| Financing Cash Flow Items | — | 19.3 | 0 |
| Other Financing Cash Flow | |||
| Cash from Financing Activities | — | 19.3 | 0 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | — | 23.2 | -18.6 |